| Jumlah Saham Beredar | 495,092 shares |
| Saham Orang Dalam | 6,134,937 shares |
| Orang Dalam Sejati | 22 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
8243 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
8161 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan LadRx Corporation transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Earl W Brien Director - [D] | 590,247 | 590,247 | |
| John Y Caloz Chief Financial Officer - [O] | 31,792 | 5,299 | |
| Joel K Caldwell Director - [D] | 335,373 | 335,373 | |
| Anita J Chawla | 180,000 | ||
| Chawla Shanta M.D. Senior VP-Drug Development - [O] | 4,200 | 700 | |
| Cheryl Cohen | 180,000 | ||
| Eric Curtis | 0 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Louis Ignarro Director - [D] | 600,785 | 600,785 | |
| Steven A Kriegsman Chief Executive Officer, Director - [D] [O] | 3,668,038 | 3,668,038 | |
| Felix Kratz | 25,000 | ||
| Daniel J Levitt EVP and Chief Medical Officer - [O] | 161,036 | 26,839 | |
| Max Link Director - [D] | 260,305 | 43,384 | |
| Ben Levin GC/VP Legal Affairs/Secy - [O] | 33,578 | 5,596 | |
|
Scott Bradford Patterson
10% Owner -
|
4,577,605 | 762,934 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Joseph Rubinfeld | 180,000 | ||
| Eric Jay Selter Director - [D] | 54,288 | 9,048 | |
| Marvin R Selter Director - [D] | 253,193 | 42,199 | |
| Simpson Jennifer K. Director - [D] | 25,000 | 25,000 | |
| Stephen Snowdy | 300,000 | ||
| Olivia C Ware | 350,000 | ||
| Wennekamp Richard L. Director - [D] | 116,965 | 19,494 | |
| Douglas Scott Wieland | 150,000 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di LADX / LadRx Corporation. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di LADX / LadRx Corporation. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk orang dalam ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-10 | 4 | Snowdy Stephen | CYTR | Stock Appreciation Right | D | 0.64 | 300,000 | 300,000 | |||||
| 2022-01-11 | 2021-12-15 | 4/A | Simpson Jennifer K. | CYTR | Stock Appreciation Right | D | 0.45 | 50,000 | 50,000 | |||||
| 2021-12-17 | 2021-12-15 | 4 | Simpson Jennifer K. | CYTR | Common Stock | D | 25,000 | 25,000 | ||||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0.26 | -150,000 | 300,000 | |||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 150,000 | 39 | 590,247 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.26 | -3,000,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -1,164,179 | -780 | 3,668,038 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 3,000,000 | 780 | 4,832,217 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Stock Option (right to buy) | D | 0.26 | -450,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -174,627 | -117 | 335,373 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 450,000 | 117 | 510,000 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.26 | -700,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -271,642 | -182 | 600,785 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 700,000 | 182 | 872,427 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 0.26 | 450,000 | 450,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0.26 | 450,000 | 450,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0.26 | 350,000 | 350,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.26 | 700,000 | 700,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.26 | 3,000,000 | 3,000,000 | |||||
| 2018-01-02 | 2017-12-15 | 4 | Kratz Felix | CYTR | Stock Option (right to buy) | D | 1.75 | 25,000 | 25,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 1.75 | 208,334 | 208,334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | CytRx Common Stock | D | 1.7500 | 387,597 | 678 | 387,597 | ||||
| 2017-12-19 | 2017-12-15 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 1.75 | 70,000 | 70,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 1.75 | 30,000 | 30,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.75 | 58,334 | 58,334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1.75 | 30,000 | 30,000 | |||||
| 2017-09-06 | 2017-07-12 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0.67 | 180,000 | 180,000 | |||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4,200 | ||||||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4,200 | ||||||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.43 | 1,250,000 | 1,250,000 | |||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.4300 | 2,325,581 | 1,000 | 2,325,581 | ||||
| 2016-12-19 | 2016-12-15 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.43 | 1,250,000 | 1,250,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0.43 | 350,000 | 350,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 0.43 | 150,000 | 150,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 0.43 | 400,000 | 400,000 | |||||
| 2016-12-09 | 3/A | Brien Earl W | CYTR | CytRx Common Stock | D | 61,484 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120,000 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120,000 | ||||||||
| 2016-12-06 | 2016-12-02 | 4 | Brien Earl W | CYTR | Stock options (right to buy) | D | 0.52 | 180,000 | 180,000 | |||||
| 2016-01-14 | 2016-01-11 | 4 | Ware Olivia C | CYTR | Stock option (right to buy) | D | 2.15 | 350,000 | 350,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | SELTER ERIC JAY | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Cohen Cheryl | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.44 | 100,000 | 100,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.44 | 300,000 | 300,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2.44 | 500,000 | 500,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2.44 | 300,000 | 300,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.44 | 1,000,000 | 1,000,000 | |||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54,288 | ||||||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54,288 | ||||||||
| 2014-12-17 | 2014-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option | D | 2.15 | 400,000 | 400,000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | RUBINFELD JOSEPH | CYTR | Stock option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.15 | 600,000 | 600,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2015-12-15 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-01-28 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 161,036 | ||||||
| 2014-01-10 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 157,983 | ||||||
| 2014-01-03 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 157,706 | ||||||
| 2014-01-03 | 2014-01-01 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 214,286 | ||||||
| 2013-12-12 | 2013-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.39 | 300,000 | 300,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2.39 | 500,000 | 500,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.39 | -180,000 | 0 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.4039 | -334,979 | -805 | 4,577,605 | ||||
| 2013-12-11 | 2013-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2.39 | 150,000 | 150,000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.39 | 925,000 | 925,000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.39 | 150,000 | 150,000 | |||||
| 2013-12-03 | 2013-12-03 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.3476 | 42,131 | 99 | 4,912,584 | ||||
| 2013-12-03 | 2013-12-02 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.3910 | 77,148 | 184 | 4,870,453 | ||||
| 2013-12-03 | 2013-11-29 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.4813 | 165,700 | 411 | 4,793,305 | ||||
| 2013-11-08 | 2013-11-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.0568 | 50,000 | 103 | 4,627,605 | ||||
| 2013-04-03 | 2013-04-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.7000 | 4,083 | 11 | 4,577,605 | ||||
| 2013-03-22 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.6100 | 3,980 | 10 | 4,573,522 | ||||
| 2013-03-20 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5704 | 8,420 | 22 | 4,569,542 | ||||
| 2013-03-20 | 2013-03-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5795 | 24,100 | 62 | 4,561,122 | ||||
| 2013-03-20 | 2013-03-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5556 | 3,000 | 8 | 4,537,022 | ||||
| 2013-03-14 | 2013-03-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5199 | 360 | 1 | 4,534,022 | ||||
| 2013-03-14 | 2013-03-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.6680 | 55,000 | 147 | 4,533,662 | ||||
| 2013-03-12 | 2013-03-08 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.46 | 74,176 | 74,176 | |||||
| 2013-01-07 | 2012-12-31 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 114,286 | ||||||
| 2013-01-02 | 2012-12-31 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 200,000 | ||||||
| 2012-12-11 | 2012-12-10 | 4/A | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | KRIEGSMAN STEVEN A | 4wa@gwgz | Stock Option (right to buy) | D | 1.83 | 500,000 | 500,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option(right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1.83 | -100,000 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1.83 | 30,000 | 30,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.05 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.80 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.04 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.46 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 7.77 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 3.99 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 23.31 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.88 | -2,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.33 | -714 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 16.45 | -1,428 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.40 | -1,428 | 0 | |||||
| 2012-10-23 | 2012-10-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5072 | 115,000 | 288 | 4,478,662 | ||||
| 2012-10-23 | 2012-10-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5129 | 65,000 | 163 | 4,363,662 | ||||
| 2012-10-18 | 2012-10-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5000 | 1,200,000 | 3,000 | 4,298,662 | ||||
| 2012-06-28 | 2012-06-28 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.9020 | 16,000 | 78 | 3,098,662 | ||||
| 2012-06-28 | 2012-06-27 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.2316 | 15,824 | 83 | 3,082,662 | ||||
| 2012-06-28 | 2012-06-26 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.3175 | 13,000 | 69 | 3,066,838 | ||||
| 2012-06-25 | 2012-06-25 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.1634 | 17,835 | 92 | 3,053,838 | ||||
| 2012-06-25 | 2012-06-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.7411 | 5,334 | 25 | 3,036,003 | ||||
| 2012-06-25 | 2012-06-21 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.6109 | 4,293 | 20 | 3,030,669 | ||||
| 2012-06-20 | 2012-06-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.6475 | 7,283 | 34 | 3,026,376 | ||||
| 2012-06-20 | 2012-06-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.4796 | 9,210 | 41 | 3,019,093 | ||||
| 2012-06-20 | 2012-06-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.2470 | 4,621 | 20 | 3,009,883 | ||||
| 2012-06-18 | 2012-06-15 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8927 | 3,558 | 14 | 3,005,262 | ||||
| 2012-06-18 | 2012-06-14 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8323 | 10,976 | 42 | 3,001,704 | ||||
| 2012-06-14 | 2012-06-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8817 | 14,176 | 55 | 2,990,728 | ||||
| 2012-06-14 | 2012-06-12 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8015 | 5,594 | 21 | 2,976,552 | ||||
| 2012-06-12 | 2012-06-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8042 | 23,399 | 89 | 2,970,958 | ||||
| 2012-06-12 | 2012-06-08 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8010 | 20,933 | 80 | 2,947,559 | ||||
| 2012-06-07 | 2012-06-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8457 | 53,635 | 206 | 2,926,626 | ||||
| 2012-06-07 | 2012-06-06 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.9659 | 24,894 | 99 | 2,872,991 | ||||
| 2012-06-07 | 2012-06-05 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8513 | 66,704 | 257 | 2,848,097 | ||||
| 2012-06-04 | 2012-06-04 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.5254 | 221,000 | 779 | 2,863,292 | ||||
| 2012-06-04 | 2012-06-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.7364 | 86,696 | 324 | 2,642,292 | ||||
| 2012-06-04 | 2012-05-31 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8324 | 190,200 | 729 | 2,555,596 | ||||
| 2012-05-31 | 3 | Patterson Scott Bradford By Spouse | CYTR | CYTR Common Stock, $0.01 par value per share | I | 81,899 | ||||||||
| 2012-05-31 | 3 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,283,497 | ||||||||
| 2012-05-15 | 2012-05-14 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-02-24 | 2012-02-23 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.3265 | 105,517 | 34 | 4,179,776 | ||||
| 2012-02-24 | 2012-02-22 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.3093 | 53,159 | 16 | 4,074,259 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Levin Ben | CYTR | Common Stock | D | 0.3265 | 22,329 | 7 | 33,578 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Levin Ben | CYTR | Common Stock | D | 0.3093 | 11,249 | 3 | 11,249 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 0.2875 | 100,000 | 29 | 100,000 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0.3265 | 74,455 | 24 | 116,965 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0.3093 | 37,510 | 12 | 42,510 | ||||
| 2012-02-24 | 2012-02-22 | 4 | SELTER MARVIN R | CYTR | Common Stock | D | 0.3120 | 100,000 | 31 | 253,193 | ||||
| 2012-02-24 | 2012-02-23 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0.3265 | 21,141 | 7 | 31,792 | ||||
| 2012-02-24 | 2012-02-22 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0.3093 | 10,651 | 3 | 10,651 | ||||
| 2012-02-24 | 2012-02-23 | 4 | LINK MAX | CYTR | Common Stock | D | 0.3265 | 136,540 | 45 | 260,305 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LINK MAX | CYTR | Common Stock | D | 0.3093 | 68,789 | 21 | 123,765 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
